Literature DB >> 12630078

Computer-assisted analysis of p53 and PCNA expression in oral lesions infected with human papillomavirus.

Christiane Pienna Soares1, Carlos Benatti Neto, Paula Andrea Gabrielli Fregonezi, Debora Barreto Teresa, Raimunda Telma de Macedo Santos, Adhemar Longatto Filho, Marina Yoshiê Sakamoto Maeda.   

Abstract

OBJECTIVE: To carry out a retrospective study to determine whether human papillomavirus (HPV) infection and immunohistochemical expression of p53 and proliferating cell nuclear antigen (PCNA) are related to the risk of oral cancer. STUDY
DESIGN: Fifty-seven oral biopsies, consisting of 30 oral squamous papillomas (OSPs) and 27 oral squamous cell carcinomas (OSCCs) were tested for the presence of HPV 6/11 and 16/18 by in situ hybridization using catalyzed signal amplification and in situ hybridization. p53 And PCNA expression was analyzed by immunohistochemistry and evaluated quantitatively by image analysis.
RESULTS: Nineteen of the 57 oral lesions (33.3%) were positive for HPV. HPV 6/11 was found in 6 of 30 (20%) OSPs and 1 of 27 (3.7%) OSCCs. HPV 16/18 was found in 10 of 27 (37%) OSCCs and 2 of 30 (6.7%) OSPs. Sixteen of the 19 HPV-positive cases (84.2%) were p53 negative; 5 (9%) were HPV 6/11 and 11 (19%) HPV 16/18, with an inverse correlation between the presence of HPV DNA and p53 expression (P = .017, P < .05). PCNA expression appeared in 18 (94.7%) of HPV positive cases, showing that HPV 16/18 was associated with intensity of PCNA expression and with OSCCs (P = .037, P < .05).
CONCLUSION: Quantitative evaluation of p53 by image analysis showed an inverse correlation between p53 expression and HPV presence, suggesting protein degradation. Image analysis also demonstrated that PCNA expression was more intense in HPV DNA 16/18 OSCCs. These findings suggest involvement of high-risk HPV types in oral carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12630078

Source DB:  PubMed          Journal:  Anal Quant Cytol Histol        ISSN: 0884-6812            Impact factor:   0.302


  6 in total

Review 1.  HPV epigenetic mechanisms related to Oropharyngeal and Cervix cancers.

Authors:  Marina Di Domenico; Giancarlo Giovane; Soumaya Kouidhi; Rosamaria Iorio; Maurizio Romano; Francesco De Francesco; Antonia Feola; Camilla Siciliano; Luigi Califano; Antonio Giordano
Journal:  Cancer Biol Ther       Date:  2018-05-14       Impact factor: 4.742

2.  The Prevalence, Anatomic Distribution and Significance of HPV Genotypes in Head and Neck Squamous Papillomas as Detected by Real-Time PCR and Sanger Sequencing.

Authors:  A Trzcinska; W Zhang; M Gitman; W H Westra
Journal:  Head Neck Pathol       Date:  2019-07-27

3.  The role of human papillomavirus in the pathogenesis of head & neck squamous cell carcinoma: an overview.

Authors:  Giuseppe Pannone; Angela Santoro; Silvana Papagerakis; Lorenzo Lo Muzio; Gaetano De Rosa; Pantaleo Bufo
Journal:  Infect Agent Cancer       Date:  2011-03-29       Impact factor: 2.965

4.  Hypoxia inducible factor-1 alpha expression is increased in infected positive HPV16 DNA oral squamous cell carcinoma and positively associated with HPV16 E7 oncoprotein.

Authors:  Vito Rodolico; Walter Arancio; Marco C Amato; Francesco Aragona; Francesco Cappello; Olga Di Fede; Giuseppe Pannone; Giuseppina Campisi
Journal:  Infect Agent Cancer       Date:  2011-10-27       Impact factor: 2.965

5.  Prevalence of human papillomavirus (HPV) in Brazil: A systematic review and meta-analysis.

Authors:  Verônica Colpani; Frederico Soares Falcetta; Augusto Bacelo Bidinotto; Natália Luiza Kops; Maicon Falavigna; Luciano Serpa Hammes; Adele Schwartz Benzaken; Ana Goretti Kalume Maranhão; Carla Magda Allan S Domingues; Eliana Márcia Wendland
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

Review 6.  Prevalence of oral and oropharyngeal human papillomavirus infection in Brazilian population studies: a systematic review.

Authors:  Leandro Luongo de Matos; Giuliana Angelucci Miranda; Claudio Roberto Cernea
Journal:  Braz J Otorhinolaryngol       Date:  2015-07-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.